ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

New CIDAC RFP Limits Recompetition To Small Business Firms

January 6, 1984

OSU Continues As comprehensive Center; City Of Hope BMT Program Wins 5-Year Grant.

July 14, 2000

In Brief: Philadelphia Chromosome Discoverer Hungerford Dead; Oregon Recruits Scientists

November 12, 1993

Executive Summary of Centers, SPOREs Report

February 28, 2003

High-Dose Chemo Doesn’t Improve Survival In Small Cell Lung Cancer

April 25, 2008

AACR Polls Members On Tentative Date for Annual Meeting

April 11, 2003